Köp aktien Scandion Oncology A/S (SCOL). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid
Scandion Oncology A/S is a manufacturer of biological products. The Company was founded in May 2017 and is located in Copenhagen, Denmark. It focuses on modern onclogy, the treatment of cancers that have developed resistance to chemotherapy.. View full business profile
2021-3-18 · Scandion Oncology A/S(CVR-no. 38 61 33 91)(the "Company")Extraordinary General Meeting to be held onFriday, November 13, 2020 at 2.00 PM (CET)at the Company's address Fruebjergvej 3, DK-2100 Copenhage Scandion Oncology A/S has agreed with Nils Brünner that he will leave his position as Chief Scientific Officer (CSO) in Scandion Oncology as of 1 April, 2021.Going forward Nils Brünner will continue as Scientific Advisor to the company and major shareholder. In 2017, Nils Brünner was one of the co-founders of Scandion Oncology and he has served as CEO until October 2020. The Board of Directors in Scandion Oncology A/S ("Scandion Oncology" or the "Company") has today, 16 November 2020, pursuant to the authorization granted by the extraordinary general meeting on 13 November 2020, resolved on a fully guaranteed new share issue of 10,711,848 shares with preferential rights for the Company's existing shareholders (the "Rights Issue"). Ikena Oncology's quiet period expires on Wednesday, May 5th. Ikena Oncology had issued 7,812,500 shares in its IPO on March 26th.
6,876.69. 2021-03-24 · SCOL | Complete Scandion Oncology A/S stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Scandion Oncology A/S (SCOL.ST) Stockholm - Stockholm Real Time Price. Currency in SEK. Add to watchlist. 19.54 +0.32 (+1.66%) As of 2:12PM CEST.
Find market predictions, SCOL financials and market news.
Shares in Scandion Oncology A/S are currently trading at SEK0.001 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Scandion Oncology A/S price has moved by % over the past year.
The total size of the offering was $125,000,000 based on an initial share price … 2018-11-23 Scandion Oncology is now in clinical phase II trials with its lead compound, SCO-101, in patients with chemotherapy-resistant colorectal cancer. In addition to SCO-101 the Company has two other drug candidates, SCO-201 and SCO-301. Scandion Oncology was listed on Spotlight Stock … PRESS RELEASEDecember 16, 2020Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced the reduction of its ownership stake in Scandion Oncology A/S (Spotlight Stock Market: SCOL) below 5%.
SCANDION ONCOLOGY A/S : Stock quote, stock chart, quotes, analysis, advice, financials and news for share SCANDION ONCOLOGY A/S | FIRST NORTH STOCKHOLM: SCOL | FIRST NORTH STOCKHOLM
SCOL.
The latest closing stock price for Cardiff Oncology as of April 09, 2021 is 9.27.. The all-time high Cardiff Oncology stock closing price was 1926.72 on June 08, 2005.; The Cardiff Oncology 52-week high stock price is 25.50, which is 175.1% above the current share price. 2020-6-22 · “The 2017 spin-out of our oncology assets into Scandion Oncology has resulted in a win-win situation, creating a highly successful cancer start-up in Scandion Oncology, while allowing Saniona to
In addition to SCO-101 the Company has two other drug candidates, SCO-201 and SCO-301. Scandion Oncology was listed on Spotlight Stock Market, Sweden in …
Find the latest Cardiff Oncology, Inc. (CRDF) stock quote, history, news and other vital information to help you with your stock trading and investing. NasdaqGS Real Time Price.
Konsultarvode projektledare
Scandion Oncology A/S is a biotechnology company formed for the purpose of addressing one of the most important challenges in modern oncology - the effective treatment of cancer which contains drug resistant cell clones or which has developed resistance to a previously prescribed cancer drug.
32,709.68. S&P 500. 3,932.37.
Baltic born coupon code
milena angel
italienska uppsala
janne josefsson lilibeth bayang
kontantfaktura skatteverket
1720681D Stock Quote - Scandion Oncology A/S - Bloomberg Markets. DJIA. 32,709.68. S&P 500. 3,932.37. NASDAQ. 13,251.11. FTSE 100. 6,761.47.
In addition to SCO-101 the Company has two other drug candidates, SCO-201 and SCO-301. Scandion Oncology was listed on Spotlight Stock Market, Sweden in November 2018. Scandion Oncology's cash burn of kr.7.6m is about 1.7% of its kr.452m market capitalisation. That means it could easily issue a few shares to fund more growth, and might well be in a position to borrow cheaply.
Karensdag aterinsjuknande
bonus malus importerade bilar
0.48 (2.4974%) 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares. For complete information, please visit the company’s website.
20.2. Trading abbreviation SCOL. ISIN-/Trading code DK0061031895.